Fibromyalgia & Central Pain Sensitization Protocol
Fibromyalgia & Central Pain Sensitization Protocol framework focused on consistent execution, practical monitoring, and safer progression.
Multi-target peptide protocol for fibromyalgia addressing central sensitization, neuroinflammation, HPA dysregulation, sleep disruption, and mitochondrial dysfunction driving widespread chronic pain.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Fibromyalgia & Central Pain Sensitization Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
16 weeks; reassess pain scores at 4, 8, and 16 weeks
Target Audience
Fibromyalgia patients with widespread pain, fatigue, and non-restorative sleep
| Compound | Dose | Frequency |
|---|---|---|
| BPC-157 BPC-157 — pain pathway modulation, NO system, opioid receptor normalization | 500 mcg oral | 2x daily |
| Selank Selank — neuroinflammatory cytokine reduction, anxiety co-morbidity | 250 mcg intranasal | Daily |
| DSIP DSIP — deep sleep restoration, growth hormone normalization during sleep | 200 mcg SQ | Daily |
| Semax Semax — endogenous opioid upregulation, BDNF for pain modulation | 300 mcg intranasal | Daily |
| SS-31 (Elamipretide) SS-31 — neuronal mitochondrial dysfunction, ATP restoration in pain neurons | 2 mg/kg SQ | Daily |
Free Peptide Guide
Fibromyalgia & Central Pain Sensitization Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned BPC-157 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Fibromyalgia & Central Pain Sensitization Protocol run before reassessment?
A common window is 16 weeks; reassess pain scores at 4, 8, and 16 weeks, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with BPC-157 + Selank execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Fibromyalgia involves central sensitization with upregulated NMDA receptors, reduced descending inhibition, and chronic neuroinflammation. BPC-157 modulates pain signaling via NO pathway and opioid receptor normalization. Selank reduces neuroinflammatory cytokines. DSIP addresses the non-restorative sleep core to fibromyalgia. Semax upregulates endogenous opioid tone. SS-31 targets the mitochondrial dysfunction in fibromyalgia neurons.
Clinical Research
No clinical references were provided for this stack yet.
More Recovery & Repair Stacks
ALS & Motor Neuron Disease Supportive Care
A neuroprotective peptide protocol for ALS and motor neuron disease, targeting mitochondrial function, neuroinflammation, and remaining motor neuron survival without interfering with standard-of-care riluzole therapy.
Acute Injury & Emergency Recovery Protocol
Rapid-response peptide protocol for acute injuries, post-surgical recovery, or critical illness support. Designed to initiate within 24–48 hours of injury or procedure.
Advanced Gut Restoration Protocol
The most comprehensive gut healing protocol, targeting intestinal permeability, mucosal growth, epithelial repair, and microbiome defense simultaneously. Suitable for celiac disease, post-antibiotic dysbiosis, IBD, short bowel syndrome, and chronic leaky gut.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Fibromyalgia & Central Pain Sensitization Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.